Dennis M. Gross
This issue provides a perspective on emerging, transformative technologies that promise to create innovations that are intended to provide solutions for significant problems in the biopharma and broader healthcare market. Many of these technologies have been evolving over the years, but remain in their early development stages technologically. As with most transformative innovations, they come with a host of lengthy and expensive challenges associated with development and validation. And, implementation of transformative business models that are at least as challenging as commercializing the technologies themselves.